Prill M, Sardao V, Sobczak M, Nowis D, Szymanski J, Wieckowski M
Cancers (Basel). 2024; 16(19).
PMID: 39409944
PMC: 11476363.
DOI: 10.3390/cancers16193324.
Peng M, Mathew N, Anderson V, Falk M, Nakamaru-Ogiso E
bioRxiv. 2024; .
PMID: 39026824
PMC: 11257584.
DOI: 10.1101/2024.07.09.602756.
Robledo-Cadena D, Pacheco-Velazquez S, Vargas-Navarro J, Padilla-Flores J, Moreno-Sanchez R, Rodriguez-Enriquez S
Mini Rev Med Chem. 2024; 24(12):1187-1202.
PMID: 39004839
DOI: 10.2174/0113895575254320231030051124.
Benzo Y, Prada J, Dattilo M, Bigi M, Castillo A, Mori Sequeiros Garcia M
Heliyon. 2024; 10(9):e30639.
PMID: 38756582
PMC: 11096749.
DOI: 10.1016/j.heliyon.2024.e30639.
Herb M
Antioxidants (Basel). 2024; 13(2).
PMID: 38397817
PMC: 10886416.
DOI: 10.3390/antiox13020219.
Oxygen and Iron Availability Shapes Metabolic Adaptations of Cancer Cells.
Wang R, Hussain A, Guo Q, Jin X, Wang M
World J Oncol. 2024; 15(1):28-37.
PMID: 38274726
PMC: 10807922.
DOI: 10.14740/wjon1739.
Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer.
Thankamony A, Ramkomuth S, Ramesh S, Murali R, Chakraborty P, Karthikeyan N
Front Oncol. 2023; 13:1230647.
PMID: 37841442
PMC: 10570535.
DOI: 10.3389/fonc.2023.1230647.
Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E, Kuzmychova H, Senthil H, Kaul E, Chokshi C, Venugopal C
Acta Neuropathol Commun. 2023; 11(1):110.
PMID: 37420311
PMC: 10327182.
DOI: 10.1186/s40478-023-01604-y.
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer.
Bassal M
Biomolecules. 2023; 13(6).
PMID: 37371524
PMC: 10296273.
DOI: 10.3390/biom13060944.
UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer.
Sun Q, Li J, Dong H, Zhan J, Xiong X, Ding J
Sci Rep. 2023; 13(1):8335.
PMID: 37221238
PMC: 10205806.
DOI: 10.1038/s41598-023-35572-z.
The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies.
Czegle I, Huang C, Soria P, Purkiss D, Shields A, Wappler-Guzzetta E
Life (Basel). 2023; 13(4).
PMID: 37109525
PMC: 10145875.
DOI: 10.3390/life13040996.
A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
Wang Y, Gao S, Xu Y, Tang Z, Liu S
Sci Rep. 2023; 13(1):3918.
PMID: 36890266
PMC: 9995529.
DOI: 10.1038/s41598-023-30927-y.
DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL.
Marco-Brualla J, de Miguel D, Martinez-Lostao L, Anel A
J Clin Med. 2023; 12(2).
PMID: 36675536
PMC: 9864242.
DOI: 10.3390/jcm12020608.
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy.
Kumar R, Mishra A, Gautam P, Feroz Z, Vijayaraghavalu S, Likos E
Cancers (Basel). 2022; 14(21).
PMID: 36358687
PMC: 9656396.
DOI: 10.3390/cancers14215268.
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer.
Poddar A, Rao S, Prithviraj P, Kannourakis G, Jayachandran A
Curr Oncol. 2022; 29(10):6847-6863.
PMID: 36290817
PMC: 9601266.
DOI: 10.3390/curroncol29100540.
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer.
Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M
Nat Metab. 2022; 4(9):1119-1137.
PMID: 36131208
DOI: 10.1038/s42255-022-00636-3.
YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration.
Li B, Wang J, Liao J, Wu M, Yuan X, Fang H
Cancer Cell Int. 2022; 22(1):287.
PMID: 36123703
PMC: 9484254.
DOI: 10.1186/s12935-022-02712-w.
Role of mitochondrial translation in remodeling of energy metabolism in ER/PR(+) breast cancer.
Koc E, Koc F, Kartal F, Tirona M, Koc H
Front Oncol. 2022; 12:897207.
PMID: 36119536
PMC: 9472243.
DOI: 10.3389/fonc.2022.897207.
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.
Lygirou V, Fasoulakis K, Stroggilos R, Makridakis M, Latosinska A, Frantzi M
Cancers (Basel). 2022; 14(15).
PMID: 35954429
PMC: 9367334.
DOI: 10.3390/cancers14153765.
Pinpointing Cancer Sub-Type Specific Metabolic Tasks Facilitates Identification of Anti-cancer Targets.
Gao S, Dai Z, Xu H, Lai L
Front Med (Lausanne). 2022; 9:872024.
PMID: 35402442
PMC: 8984102.
DOI: 10.3389/fmed.2022.872024.